The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Altimmune Inc (NASDAQ: ALT) closed at $3.67 up 6.69% from its previous closing price of $3.44. In other words, the price has increased by $6.69 from its previous closing price. On the day, 5.17 million shares were traded. ALT stock price reached its highest trading level at $3.7 during the session, while it also had its lowest trading level at $3.4289.
Ratios:
For a deeper understanding of Altimmune Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.41 and its Current Ratio is at 20.41. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.Stifel initiated its Buy rating on January 08, 2025, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 323904288 and an Enterprise Value of 156648112. For the stock, the TTM Price-to-Sale (P/S) ratio is 16194.94 while its Price-to-Book (P/B) ratio in mrq is 1.93. Its current Enterprise Value per Revenue stands at 7832.406 whereas that against EBITDA is -1.662.
Stock Price History:
The Beta on a monthly basis for ALT is 0.17, which has changed by -0.44478065 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -14.37%, while the 200-Day Moving Average is calculated to be -38.11%.
Shares Statistics:
For the past three months, ALT has traded an average of 5.74M shares per day and 3042190 over the past ten days. A total of 88.26M shares are outstanding, with a floating share count of 87.34M. Insiders hold about 1.04% of the company’s shares, while institutions hold 42.98% stake in the company. Shares short for ALT as of 1755216000 were 25460460 with a Short Ratio of 4.43, compared to 1752537600 on 28097407. Therefore, it implies a Short% of Shares Outstanding of 25460460 and a Short% of Float of 29.060000000000002.
Earnings Estimates
The firm’s stock currently is rated by 8.0 analysts. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.27 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$0.96 and -$1.27 for the fiscal current year, implying an average EPS of -$1.13. EPS for the following year is -$1.4, with 8.0 analysts recommending between -$1.06 and -$1.82.
